Leading the way to safer medication
 Crosscheck  Recommender

AFINITOR

Found in: Austria Australia Canada Cyprus Spain France Netherlands Singapore United Kingdom United States

Active Ingredients

#
Chemical substance
Description
1
Everolimus

Everolimus is a selective mTOR (mammalian target of rapamycin) inhibitor. mTOR is a key serine-threonine kinase, the activity of which is known to be upregulated in a number of human cancers.

ATC Classification

Code
Title
Category
L01EG02
Everolimus
L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors

Identifiers

Authority
Identifier(s)
FDA, National Drug Code (US)
Identifier(s): 0078-0566, 0078-0567, 0078-0594, 0078-0620, 0078-0626, 0078-0627, 0078-0628
Health Products and Food Branch (CA)
Identifier(s): 02339501, 02339528, 02369257, 02425645, 02425653, 02425661
Health Sciences Authority (SG)
Identifier(s): 13749P, 13750P, 14130P
Pharmaceutical Benefits Scheme (AU)
Identifier(s): 10131F, 10132G, 10133H, 10135K, 11254H, 11257L, 11258M, 11262R, 11267B, 11362B, 11377T, 11591C, 11592D, 11598K, 11599L, 11607X, 11608Y, 2818H, 2819J, 2985D
Z-Index G-Standaard PRK (NL)
Identifier(s): 100471, 92568, 92576
Base de données publique des médicaments (FR)
Identifier(s): 62142469, 64201368, 69867865
Centro de información online de medicamentos de la AEMPS (ES)
Identifier(s): 09538001, 09538004